Plant-based Cancer Drug Discovery

Prof. Jamal Mahajna

Principal Researcher

Latest Publications

Ovarian cancer ascites confers platinum chemoresistance to ovarian cancer cells

Yifat Koren Carmi, Abed Agbarya, Hazem Khamaisi, Raymond Farah, Yelena Shechtman, Roman Korobochka, Jacob Gopas, Jamal Mahajna
Read Online
Prof. Jamal Mahajna
2024

Secreted soluble factors from tumor-activated mesenchymal stromal cells confer platinum chemoresistance to OC cells and JAK and c-MET kinase inhibitors restore platinum sensitivity to ovarian cancer cells

Yifat Koren Carmi, Hazem Khamaisi, Jacob Gopas and Jamal Mahajna
Read Online
Prof. Jamal Mahajna
Int. J. Mol. Sci. 2023, 24(9), 7730; 
2023

Plant-derived epi-nutraceuticals as Potential Broad-Spectrum Anti-Viral Agents

Gabbianelli, R.; Shahar, E.; De Simone, G.; Rucci, C.; Bordoni, L.; Feliziani, G.; Zhao, F.; Ferrati, M.; Maggi, F.; Spinozzi, E.; Mahajna, J.
Read Online
Prof. Jamal Mahajna
Nutrients 2023, 15(22), 4719;
2023

Compounds originating from the edible mushroom Auricularia auricula-judae inhibit tropomyosin receptor kinase B activity

Orr Shahar, Idan Pereman, Hazem Khamisie, Nirit Ezov, Ofer Danay, Ali Khattib, Ron schweitzer, Soliman Khatib and Jamal Mahajna
Read Online
Prof. Jamal Mahajna
Heliyon, e13756
2023
More Publications

In the Media

The potential use of natural products to negate hepatic, renal and neuronal toxicity induced by cancer therapeutics